# Filing Detail

Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001104659-25-040398
Filing Date
2025-04-29
Accepted
2025-04-28 20:17:20
Documents
35

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | S-4/A | tm256615-9_s4a.htm | S-4/A | 8083138
2 | EXHIBIT 8.1 | tm256615d10_ex8-1.htm | EX-8.1 | 16419
3 | EXHIBIT 10.30 | tm256615d10_ex10-30.htm | EX-10.30 | 98558
4 | EXHIBIT 10.31 | tm256615d10_ex10-31.htm | EX-10.31 | 89665
5 | EXHIBIT 10.32 | tm256615d10_ex10-32.htm | EX-10.32 | 43889
6 | EXHIBIT 10.33 | tm256615d10_ex10-33.htm | EX-10.33 | 44491
7 | EXHIBIT 10.36 | tm256615d10_ex10-36.htm | EX-10.36 | 138904
8 | EXHIBIT 10.52 | tm256615d10_ex10-52.htm | EX-10.52 | 231470
9 | EXHIBIT 10.53 | tm256615d10_ex10-53.htm | EX-10.53 | 216245
10 | EXHIBIT 10.54 | tm256615d10_ex10-54.htm | EX-10.54 | 248293
11 | EXHIBIT 23.1 | tm256615d10_ex23-1.htm | EX-23.1 | 2033
12 | EXHIBIT 23.2 | tm256615d10_ex23-2.htm | EX-23.2 | 1996
13 | EXHIBIT 23.4 | tm256615d10_ex23-4.htm | EX-23.4 | 5338
14 | EXHIBIT 99.6 | tm256615d10_ex99-6.htm | EX-99.6 | 3147
15 | EX-FILING FEES | tm256615d10_ex-filingfees.htm | EX-FILING FEES | 43120
16 | GRAPHIC | bc_inhibitors-4c.jpg | GRAPHIC | 52077
17 | GRAPHIC | bc_paidvsnetincome-4c.jpg | GRAPHIC | 34273
18 | GRAPHIC | bc_paidvstsr-4c.jpg | GRAPHIC | 34272
19 | GRAPHIC | fc_chemotherapy-4clr.jpg | GRAPHIC | 96809
20 | GRAPHIC | fc_cr002adc-4c.jpg | GRAPHIC | 85532
21 | GRAPHIC | ft_lucidcapnewyork-bw.jpg | GRAPHIC | 6723
22 | GRAPHIC | lc_cooperative-4c.jpg | GRAPHIC | 64616
23 | GRAPHIC | lc_nsclc-4clr.jpg | GRAPHIC | 78916
24 | GRAPHIC | lg_crescent-4clr.jpg | GRAPHIC | 13366
25 | GRAPHIC | lg_glycomimetics-4c.jpg | GRAPHIC | 33723
26 | GRAPHIC | lg_lucidcapital-bwlr.jpg | GRAPHIC | 7806
27 | GRAPHIC | lg_walkers-bwlr.jpg | GRAPHIC | 4795
28 | GRAPHIC | ph_antivegf-4c.jpg | GRAPHIC | 83797
29 | GRAPHIC | ph_cr001-4clr.jpg | GRAPHIC | 108813
30 | GRAPHIC | ph_vegf-4clr.jpg | GRAPHIC | 44251
31 | GRAPHIC | sg_lucidcapitalmarkets-bw.jpg | GRAPHIC | 6380
32 | GRAPHIC | tb_clinicaldevelop-4c.jpg | GRAPHIC | 62088
33 | GRAPHIC | tb_pfs-4c.jpg | GRAPHIC | 26172
34 | GRAPHIC | tm256615d10_ex8-1img01.jpg | GRAPHIC | 3476
35 | GRAPHIC | tm256615d10_ex23-4img001.jpg | GRAPHIC | 3268
| Complete submission text file | 0001104659-25-040398.txt |  | 10430215

Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-285035 | Film No.: 25882281
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)